tradingkey.logo
tradingkey.logo
検索

Vivos Therapeutics Inc

VVOS
ウォッチリストに追加
0.453USD
-0.045-9.05%
終値 07/02, 13:00ET15分遅れの株価
4.21M時価総額
損失額直近12ヶ月PER

詳細情報 Vivos Therapeutics Inc 企業名

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Vivos Therapeutics Incの企業情報

企業コードVVOS
会社名Vivos Therapeutics Inc
上場日Dec 11, 2020
最高経営責任者「CEO」Huntsman (R. Kirk)
従業員数109
証券種類Ordinary Share
決算期末Dec 11
本社所在地7921 Southpark Plaza,
都市LITTLETON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号80120
電話番号18669084867
ウェブサイトhttps://vivos.com/
企業コードVVOS
上場日Dec 11, 2020
最高経営責任者「CEO」Huntsman (R. Kirk)

Vivos Therapeutics Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

よくある質問

Vivos Therapeutics Incの上位5名の株主は誰ですか?

Vivos Therapeutics Incの上位5名の株主は以下のとおりです。Mr. Bradford K. (Brad) Amman

Vivos Therapeutics Inc(VVOS)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Vivos Therapeutics Incの株式を保有している機関は50社あり、保有株式の総市場価値は約1.10Mで、全体の8.12%を占めています。2025Q4と比較して、機関の持ち株は-71775.00増加しています。

Vivos Therapeutics Incの最大の収益源は何ですか?

2026Q1において、Sleep testing services部門がVivos Therapeutics Incにとって最大の収益を生み出しており、その金額は2.56Mで、全収益の37.74%を占めています。